Angiotensin-II-receptor inhibitors in pregnancy.
Hinsberger
A
A
Wingen
A M
AM
Hoyer
P F
PF
D000014:Abnormalities, Drug-Induced / Q000209:etiology*; D058186:Acute Kidney Injury / Q000139:chemically induced*; D000328:Adult; D000959:Antihypertensive Agents / Q000008:administration & dosage / Q000009:adverse effects*; D001562:Benzimidazoles / Q000008:administration & dosage / Q000009:adverse effects*; D001713:Biphenyl Compounds; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D006973:Hypertension / Q000175:diagnosis / Q000188:drug therapy*; D007668:Kidney / Q000002:abnormalities* / Q000000981:diagnostic imaging; D007677:Kidney Function Tests; D011247:Pregnancy; D011249:Pregnancy Complications, Cardiovascular / Q000175:diagnosis / Q000188:drug therapy*; D011256:Pregnancy Outcome; D018570:Risk Assessment; D013777:Tetrazoles / Q000008:administration & dosage / Q000009:adverse effects*; D014463:Ultrasonography
D000959:Antihypertensive Agents; D001562:Benzimidazoles; D001713:Biphenyl Compounds; D013777:Tetrazoles; C081643:candesartan